The liver-specific SIRT2-KO mice were produced by crossing SIRT2flox/flox mice obtained from Johan Auwerxd Laboratory (Switzerland)47 (link) and Alb-Cre mice purchased from Jackson Laboratory (USA) in a C57BL/6 background. Recombinant AAV8 constructs expressing targeted mouse SIRT2, SIRT2-H187A, LCN2, C/EBPβ, or mutated C/EBPβ (K101R and K102R) under the control of TBG promoter were generated by Sunbio Techservice Inc. (Shanghai, China). A noncoding plasmid carrying only the TBG promoter was used to produce control vector particles. All animals received care in compliance with protocols approved by the Institutional Animal Use and Care Committee of Shanghai Jiaotong University School of Medicine.
Free full text: Click here